114 related articles for article (PubMed ID: 18485013)
21. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
[TBL] [Abstract][Full Text] [Related]
22. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
Rodríguez-Pinto D; Moreno J
Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
[TBL] [Abstract][Full Text] [Related]
23. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
24. Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation.
Zerbini A; Pilli M; Fagnoni F; Pelosi G; Pizzi MG; Schivazappa S; Laccabue D; Cavallo C; Schianchi C; Ferrari C; Missale G
J Immunother; 2008 Apr; 31(3):271-82. PubMed ID: 18317360
[TBL] [Abstract][Full Text] [Related]
25. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
[TBL] [Abstract][Full Text] [Related]
26. Human hepatoma cells expressing HLA class I molecules stimulate primary responses of purified CD8+ T lymphocytes.
Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Barnaba V
Res Virol; 1993; 144(4):327-32. PubMed ID: 8105523
[TBL] [Abstract][Full Text] [Related]
27. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
Maccalli C; Di Cristanziano V; Fodale V; Corsi D; D'Agostino G; Petrangeli V; Laurenti L; Guida S; Mazzocchi A; Arienti F; Perrone MP; Castelli C; Rivoltini L; Zagonel V; Tartaglia M; Parmiani G; Belardelli F
Clin Cancer Res; 2008 Nov; 14(22):7292-303. PubMed ID: 18974390
[TBL] [Abstract][Full Text] [Related]
28. Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.
Calderhead DM; DeBenedette MA; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
J Immunother; 2008 Oct; 31(8):731-41. PubMed ID: 18779746
[TBL] [Abstract][Full Text] [Related]
29. Murine model of CD40-activation of B cells.
Liebig TM; Fiedler A; Klein-Gonzalez N; Shimabukuro-Vornhagen A; von Bergwelt-Baildon M
J Vis Exp; 2010 Mar; (37):. PubMed ID: 20208476
[TBL] [Abstract][Full Text] [Related]
30. Induction of cytotoxic T cell response against HCA661 positive cancer cells through activation with novel HLA-A *0201 restricted epitopes.
Pang PH; Chan KT; Tse LY; Chan RC; Cheung YK; Sin FW; Guo ZH; Xie Y
Cancer Lett; 2007 Oct; 256(2):178-85. PubMed ID: 17624664
[TBL] [Abstract][Full Text] [Related]
31. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
[TBL] [Abstract][Full Text] [Related]
32. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
33. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
[TBL] [Abstract][Full Text] [Related]
34. Identification of T-cell epitopes by a novel mRNA PCR-based epitope chase technique.
Doucet JD; Gauchat D; Lapointe R
J Immunother; 2011 Mar; 34(2):183-6. PubMed ID: 21304402
[TBL] [Abstract][Full Text] [Related]
35. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
36. CD40 activation: lessons for HIV immunotherapy from malignancies?
Le Dieu R; Gribben J
J HIV Ther; 2005 Sep; 10(3):51-5. PubMed ID: 16385972
[TBL] [Abstract][Full Text] [Related]
37. Modification of dendritic cells with interferon-gamma-inducible protein-10 gene to enhance vaccine potency.
Kang TH; Bae HC; Kim SH; Seo SH; Son SW; Choi EY; Seong SY; Kim TW
J Gene Med; 2009 Oct; 11(10):889-98. PubMed ID: 19618483
[TBL] [Abstract][Full Text] [Related]
38. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.
Hofmann C; Harrer T; Kubesch V; Maurer K; Metzner KJ; Eismann K; Bergmann S; Schmitt-Haendle M; Schuler G; Dörrie J; Schaft N
AIDS; 2008 Aug; 22(13):1577-82. PubMed ID: 18670216
[TBL] [Abstract][Full Text] [Related]
39. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of allergic responses by CD40 gene silencing.
Suzuki M; Zheng X; Zhang X; Ichim TE; Sun H; Kubo N; Beduhn M; Shunnar A; Garcia B; Min WP
Allergy; 2009 Mar; 64(3):387-97. PubMed ID: 19175598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
